Centralized Monitoring: Exploring the Considerations and Challenges of Implementation

Innovaderm's Associate Director - Risk Based Quality Management, Rohit Gupta, contributed to PHUSE's white paper entitled: “Centralized Monitoring: Exploring the Considerations and Challenges of Implementation”.

Innovaderm is proud to have been involved in the development of such a document addressing:

1. The key success measures & best practices to ensure a well-connected end-to-end component of risk-based quality management;

2. The positive impact centralized monitoring can have on data quality, patient safety & clinical trial efficiencies;

3. The current & future needs of holistic central monitoring, the potential early-phase study risk reduction, and decrease of preventable errors.

Reinforce your centralized monitoring knowledge and expertise by reading this white paper now.

Any questions regarding centralized monitoring and risk-based quality management?

Newsletter

Join our science community with Press Forward, our quarterly newsletter. Get the latest in dermatology clinical research. Subscribe now!

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.

Blog Article

6 Effective Strategies to Boost Patient Recruitment in Dermatology and Rheumatology Trials

Table of Contents Corrective Data Mining Best Practices to Accelerate Recruitment and Local Advertising Consider Using Imagery in Pre-Screening Digital Advertisement Campaigns and Their Impact Secondary Screening Recruitment Start Date In the ever-evolving landscape of clinical trials, patient recruitment strategies stand as a critical component. The ability to effectively and efficiently recruit patients can significantly […]

Case Study

Success Story: Support for Vitiligo Pre-IND Submission and FDA Meeting Preparation

Project Overview The client sought support for their pre-IND (Investigational New Drug) submission and development program. Our goal was to contribute to the clinical section of the pre-IND submission package and prepare clinical questions for their Vitiligo asset. Steps and Actions Taken Steps Actions Pre-IND Submission Development Clinical Section […]

Blog Article

Backup Plans in Clinical Trials: A Focus on Rheumatology

Table of Contents Common Types of Backup Plans in Rheumatology Clinical Trials Adapting to Evolving Therapies in Rheumatology Trials Backup Countries Protocol Amendments: A Proactive Strategy Positive Impact of Backup Sites on the Conduct of the Study Financial Impact of Backup Sites Rheumatology clinical trials, by their very nature, are unpredictable. Unforeseen complications can arise, […]